6 ePosters
Session Name- SHORT ORAL SESSION 16: MISCELLANEOUS 06
Filtered By
- SHORT ORAL SESSION 16: MISCELLANEOUS 06
Sort By
Relevance
AS65 Stigma and Mental Illness
CREATIVITY AND SEXUAL ORIENTATION
Presentation Number
SO006
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter
Authors
AS60 Rehabilitation of people with mental disorders
NO POSTER UPLOADED
CONCEPT OF REHABILITATION AND NEPALESE PERSPECTIVES
Presentation Number
SO004
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter
Authors
AS44 Neuromodulation (including DBS, TMS; tDCS, VNS; Neurofeedback)
NEUROMODULATION IN EATING DISORDERS, OBESITY AND FOOD CRAVING: CAN WE UNDERSTAND THE NEUROBIOLOGY?
Presentation Number
SO001
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter
AS60 Rehabilitation of people with mental disorders
VALIDATION OF MALAY VERSION OF RECOVERY KNOWLEDGE INVENTORY (RKI-M) AMONG MENTAL HEALTH PROVIDERS IN URBAN AND RURAL AREA IN MALAYSIA: A CROSS-SECTIONAL STUDY
Presentation Number
SO005
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter
Authors
AS44 Neuromodulation (including DBS, TMS; tDCS, VNS; Neurofeedback)
CYTOKINE CRISIS/STORM IN COVID-19 PATIENTS: CAN TRANSCRANIAL MAGNETIC STIMULATION HELP?
Presentation Number
SO002
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter
AS44 Neuromodulation (including DBS, TMS; tDCS, VNS; Neurofeedback)
WHY WE SHOULD NOT FOLLOW FDA GUIDELINES WHEN IT COMES TO TRANSCRANIAL MAGNETIC STIMULATION TREATMENT
Presentation Number
SO003
Presentation Type
Late breaking Abstract Submisison
Session Name
2370 - SHORT ORAL SESSION 16: MISCELLANEOUS 06 (ID 556)
Presenter